Pathology Informaticist and Molecular Pathologist. Diplomate in AP/CP, MGP and Clinical Informatics. My opinions are my own. Following does not mean endorsing.
Atlanta, GA
Joined March 2009
- Tweets3.4K
- Following1.1K
- Followers1.3K
- Likes3.9K
Alexis Carter, MD retweeted
In molecular diagnostics, computer hardware is part of the test system under CLIA. Validated pipeline versions have to be tied to the assay that was run; the laboratory director approves code changes before implementation. Some accreditors require FASTQ, BAM, and VCF files for a minimum of 2 years. HIPAA requires audit trails for 6 years. Cloud and instrument vendors that store or transmit genetic information need a written business associate agreement even if they cannot unencrypt the data.
Schmidt, @PathByteChic, and colleagues (J Mol Diagn. 2025) map the hardware, software, networks, and interoperability requirements for bioinformatics inside a CLIA laboratory. The article is not legal advice.
jmdjournal.org/article/S1525…
Alexis Carter, MD retweeted
Study of 86K AI responses for marketing mgrs, IT mgrs & mgmt consultants finds AI recommended higher salary targets for male applicants (Claude: $16K more;GPT $2.7K more). Women told to negotiate for remote work, flex hrs & parental leave. Men: more money
forbes.com/sites/kimelsesser…
Alexis Carter, MD retweeted
It's finally here. The @CLSI_LabNews AUTO14 standard on 2D Bar Coding for Anatomic and Clinical Laboratories has been published today! 🎉🎉 It's a one stop shop for universal identification of specimens and more. clsi.org/shop/standards/auto…
Alexis Carter, MD retweeted
We will be hosting a series of broadcasts about essential bioinformatics roles, responsibilities and competencies for professionals in clinical molecular diagnostic laboratories, based on a 2025 collection of papers published in @JMDiagn.
Learn more: amp.org/events/amp-events-ca…
ALT Clinical Practice Update banner highlighting 'Body of Knowledge' for clinical bioinformaticians with AMP logo.
Alexis Carter, MD retweeted
In a study of professors, women got 378 new work requests over 4 wks vs 118 for men. Women spent more time on service, advising & teaching; men on research. Orgs should track who is taking extra duties & ensure they are rewarded and distributed fairly. forbes.com/sites/kimelsesser…
Alexis Carter, MD retweeted
We convened an expert working group to update the guideline for 🧬classification, annotation, interpretation and reporting of somatic sequence variants🧬 (originally published in 2017).
The working group is seeking comments on its draft recommendations: amp.org/clinical-practice/op….
Alexis Carter, MD retweeted
Congratulations to @JMDiagn Editor in Chief Dr. Ron Przygodzki on winning the 2024 Jeffrey A. Kant Leadership Award, which is @AMPath's highest honor, given for exceptional leadership in advancing the mission and goals of the Association for Molecular Pathology.
@gizbab
AMP is honored to announce the recipients of its 2024 Recognition Awards, which will be presented at #AMPath24 in Vancouver this November. Congratulations to Dr. Atul Butte, Dr. Ronald Przygodzki, and Dr. Eric Konnick!
Read the full press release: ow.ly/LVAH50SUf9u
Alexis Carter, MD retweeted
Very sad new for the International Pathology Community of a legend. Vale Dr Christopher Fletcher.
Alexis Carter, MD retweeted
Finally made it to "the mothership" for a bit of training! There are several familiar names online as well @pathbytes @PathByteChic @ctlin1 – at Verona, WI
Alexis Carter, MD retweeted
It was a super exciting to be on the podcast “talk python to me” and discuss how python is used in genomics, molecular pathology, and patient care!! Thank you @mkennedy for having me on your show. @Aparwani_dpath @PathPro @AMPath @PathByteChic youtube.com/watch?v=L6AAOmob…
Alexis Carter, MD retweeted
Just a few more days for #AMPEurope2024!! Looking forward to an amazing conference. @AMPath #moleculardiagnostics #genomics #molecularpathology #biomarkers #precisionmedicine
Alexis Carter, MD retweeted
In light of this week's webinar, our #CitationSpotlight is on the 2022 paper "EHRs & #Genomics Perspectives from @AMPath #EHR #Interoperability for #ClinicalGenomics Data Working Group" by @PathByteChic, @JulieWoolworth, @Robyn_Temple, @ahmetz, @roysomak4
sciencedirect.com/science/ar…
ALT A white graphic reading "PhenoTIps Citation Spotlight" featuring the PhenoTips logo and bubbles of different blue shades.
Alexis Carter, MD retweeted
Spotted at #ASPHO2024: Erin Seibel, MMSc, CGC, presenting a poster on the impact of having a full-time genetic counselor embedded in a cancer survivorship program.
Alexis Carter, MD retweeted
Interested in the #moldx of genetic and inherited conditions? All the latest #genetics papers published in @JMDiagn can be found in one spot online: jmdjournal.org/content/genet…
Alexis Carter, MD retweeted
Selfie with one of the most cited individuals on the planet, Dr @AhJemal . The man responsible for the annual statistics on cancer incidence and mortality @AmericanCancer. Together we are at >800k citations, though my contribution is 0.5% 😉 – at Druid Hills, GA
Alexis Carter, MD retweeted
Consider @JMDiagn as a destination for your next #moldx #molpath advancements! JMD publishes along the 5 subdivions of @AMPath - #Genetics, #Informatics, #SolidTumor, #InfectiousDisease, and #Hematopathology.
Submission is free-www2.cloud.editorialmanager.…
Alexis Carter, MD retweeted
FANTASTIC testimony by Dr. Dara Aisner on the potential impact of the FDA proposed ruling for LDT in today’s Health Subcommittee Hearing on Regulation of Diagnostic Tests ! Thank you @AMPath staff as well… I c u🫶🏽! Replay here 👉🏽 m.youtube.com/@energyandcomm…
Alexis Carter, MD retweeted
Join us May 20-23, 2024, at the Ann Arbor Marriott at Eagle Crest Resort for PI Summit 2024 - the LEADING meeting in Pathology Informatics! Learn more or REGISTER at pathologyinformatics.org/pi-…
Book your room at our discounted group rate at book.passkey.com/e/50618862
#PISUMMIT24
Alexis Carter, MD retweeted
Roses are Red
Laboratory developed tests are complicated
But under duplicative CMS/CLIA and FDA oversight
They’ll be over-regulated.
ow.ly/Hl6L50QAFBa
#HealthPolicyValentine #LDTs #LDPs #pathologists
